Impaired oxidative phosphorylation drives primary tumor escape and metastasis
Emily N. Arner(Vanderbilt University Medical Center), Jeffrey C. Rathmell(University of Chicago), Evan Krystofiak(Vanderbilt University), Zachary A. Bacigalupa(Nashville Oncology Associates), Martin Lang(Eurac Research), Matthew A. Cottam(Vanderbilt University), Samuel Schaefer, Frank M. Mason(Vanderbilt University), Yuki Shibata(Cancer Institute (WIA)), Allison E. Sewell(Vanderbilt University Medical Center), KayLee K. Steiner(Vanderbilt University Medical Center), Erin Q. Jennings(Vanderbilt University Medical Center), Kamran Idrees(Nashville Oncology Associates), Kathryn E. Beckermann(Vanderbilt University Medical Center), Nunziata Maio(Eunice Kennedy Shriver National Institute of Child Health and Human Development), W. Kimryn Rathmell(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Darren R. Heintzman(Vanderbilt University Medical Center), Daniel R. Crooks(National Cancer Institute), Logan Vlach(University School of Nashville), Melissa M. Wolf(Vanderbilt University), Alexander M. Blatt(Nashville Oncology Associates), Zaid Hatem(Vanderbilt University Medical Center), Xiang Ye(Qilu Hospital of Shandong University), C. Ricketts(National Cancer Institute), Emma Hathaway(Dana-Farber Cancer Institute), Marston Linehan(Cancer Institute (WIA)), Emilie L. Fisher(Nashville Oncology Associates)
Cited by 4
Related Papers
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
|The Journal of Immunology|2008|836
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791